Meet the Team
Hector Adrian Duque Martinez, PhD
Lead Biologist
Dr. Héctor is the Lead Biologist at the US Mexico Cancer Institute. With a Doctorate in Molecular Biomedicine and extensive experience in immunotherapy, Dr. Duque brings scientific rigor and clinical precision to every treatment. His leadership in Natural Killer (NK) cell research has helped shape advanced, patient-centered care rooted in biology, not guesswork.
Paul Whiting and Sherri Whiting
The Founders
Paul Whiting and Sherri Whiting are the founders of the US Mexico Cancer Institute. Driven by a personal mission to create a more compassionate and scientifically grounded approach to cancer care, they established the institute to bridge innovation and empathy. Their leadership continues to shape a patient-first environment where hope is supported by cutting-edge science.
Ivan Portillo Pacheco, MD
Clinical Director
Dr. Ivan serves as the Clinical Director of the US Mexico Cancer Institute. With a strong background in integrative oncology and patient-focused care, he oversees treatment protocols to ensure every patient receives safe, effective, and personalized therapy. His guidance brings together advanced science and compassionate support at every stage of care.
Meet the Team
Paul Whiting and Sherri Whiting
Paul and Sherri Whiting are the visionary founders of the US Mexico Cancer Institute. Motivated by a deeply personal mission, they sought to create a cancer treatment center that blends scientific innovation with compassion and human dignity. Their leadership reflects a commitment to offering patients not just advanced therapies, but also an environment of trust, care, and hope.
Through their guidance, the institute has become a place where cutting-edge research meets patient-centered care, ensuring that every individual receives treatment rooted in both science and empathy. Their continued dedication shapes the institute’s culture of integrity, compassion, and innovation.
What Paul & Sherri Offer
Vision & Mission:
Founded the institute to bridge innovation with compassion in cancer care.
Committed to creating a patient-first environment.
Driven by a personal mission to transform the cancer treatment experience.
Leadership & Direction:
Provide strategic guidance that balances science, care, and accessibility.
Shape the institute’s culture of empathy, trust, and scientific integrity.
Ensure the institute stays aligned with its mission of patient-centered healing.
Patient-Centered Care:
Advocate for treatments that combine medical precision with emotional support.
Promote a holistic approach where hope and healing go hand in hand.
Ensure patients and families feel valued, heard, and supported.
Why Dr. Portillo
Clinical Expertise
Strong background in integrative oncology.
Oversees and develops personalized treatment protocols.
Ensures therapies are both safe and effective.
Patient-Focused Leadership
Leads the institute’s clinical operations and patient care standards.
Prioritizes a holistic approach that balances treatment with emotional well-being.
Guides patients through every stage of care with trust and empathy.
Integration of Science & Care
Combines conventional medicine with advanced therapies.
Bridges scientific research and real-world clinical practice.
Ensures protocols remain evidence-based and patient-specific.
Commitment to Excellence
Advocates for high-quality, individualized care.
Promotes a culture of compassion, safety, and precision.
Strengthens the institute’s reputation as a leader in integrative cancer treatment.
Ivan Del Portillo Pacheco, MD
Dr. Ivan Portillo Pacheco is the Clinical Director of the US Mexico Cancer Institute, where he combines medical expertise with compassionate care to guide patients through their healing journey. With a strong background in integrative oncology, Dr. Portillo specializes in uniting conventional medicine with advanced therapies to create personalized treatment protocols that prioritize both safety and effectiveness.
His leadership ensures that every patient benefits from a comprehensive, patient-centered approach—one that values not only clinical outcomes but also quality of life. By aligning medical science with empathy, Dr. Portillo provides direction that supports patients at every stage of care, offering both hope and trusted guidance.
Héctor Adrián Duqué Martínez, PhD
Dr. Héctor Adrián Duqué Martínez is the Lead Biologist at the US Mexico Cancer Institute, specializing in Molecular Biomedicine and Immunotherapy. With a Doctorate in Molecular Biomedicine and years of dedicated research, he has become a recognized leader in Natural Killer (NK) cell therapy, one of the most promising frontiers in cancer treatment.
Dr. Duqué’s expertise lies in translating complex biological research into safe, effective, and patient-centered therapies. His leadership ensures that every treatment is grounded in rigorous science, clinical precision, and a commitment to improving outcomes for patients seeking advanced cancer care.
Why Dr Duqué Martínez
Scientific & Clinical Expertise
Specialized knowledge in Molecular Biomedicine and cancer biology.
Extensive background in immunotherapy development and application.
Pioneer in Natural Killer (NK) cell research and therapies.
Patient-Focused Treatment Contributions
Development of personalized, biology-driven treatment protocols.
Guidance on cellular therapies such as NK cells and stem cells.
Ensures all therapies are evidence-based and clinically safe.
Research & Innovation
Leads clinical studies advancing immunotherapy and cancer biology.
Innovates new methods for NK cell expansion and application.
Publishes and shares findings to strengthen global cancer research.
Leadership & Mentorship
Provides scientific direction for the institute’s treatment programs.
Trains and mentors staff in cell biology, immunology, and clinical practices.
Acts as a bridge between laboratory research and real-world patient care.